Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Influenza neuraminidase (NA) is a surface glycoprotein antigen found on influenza viruses, including both influenza A and B strains. It is an exosialidase enzyme that cleaves terminal sialic acid residues, which is essential for viral release from infected cells and subsequent spread. NA is a major target for antiviral drugs and a potential component of next-generation influenza vaccines.
Inhibition of neuraminidase enzyme activity, preventing virion release from infected cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza Neuraminidase Antigen (NA).